Novarad

Novarad is an established, privately-held health technology company specializing in enterprise medical imaging and workflow software. With over 30 years of operation, it has evolved from a traditional PACS provider to an innovator in augmented reality (AR) surgical guidance, as evidenced by its FDA-cleared VisAR system. The company generates revenue through its SaaS and software licensing model, catering to a diverse range of healthcare providers from large hospitals to rural clinics. Its strategy combines reliable core imaging IT with cutting-edge surgical navigation to improve clinical outcomes and operational efficiency.

Enterprise medical imaging software platform (NovaPACS EI) and a fully immersive 3D Augmented Reality surgical navigation system (VisAR). The platform supports cloud, on-premises, edge, and hybrid deployments and includes specialized modules for cardiology and mammography.

In enterprise imaging, Novarad competes with large diversified players like GE HealthCare, Philips, and Fujifilm, as well as other PACS specialists. In augmented reality surgical navigation, it competes with companies like Augmedics (xvision), Medivis, and the surgical navigation divisions of large ortho/neuro companies (e.g., Medtronic, Stryker) who are also exploring AR/VR applications.